Published in Patient Preference and Adherence – 2022
Collaborator: Janssen Global
Authors: Joyce LaMori, Antoine Seignez, Lise Radoszycki
Human immunodeficiency virus (HIV)-1 infection remains a concern. As patient adherence to antiretroviral therapy is essential to avoid drug resistance and virologic failure, greater understanding of patient treatment satisfaction may help facilitate ongoing medication use.
This descriptive study assessed patient satisfaction with DRV/c/FTC/TAF and HIV-related symptoms at baseline and follow-up (4– 6 weeks).